AtaCor Medical announced today that it entered a financing worth up to $75 million to support its U.S. FDA pivotal study.

The global market for Subcutaneous Implantable Defibrillator Systems is projected to experience robust growth over the next ...

AtaCor Medical has raised $75m financing to support a study of its extravascular implantable cardioverter-defibrillator ...

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management systems, ...

With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC ...

In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately ...

A woman who found the nearest defibrillator to her home was not working when her mother was having a medical emergency has called for better maintenance of the devices on the Isle of Man. Lynsey ...

The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. With ...

Imagine a world where surgeons are guided by AI to perform complex operations with the precision of world-class experts and where life-saving surgery reaches remote corners of the globe through ...

The implantable defibrillator market is poised for healthy growth through 2035, fueled by the rising global incidence of ...

Adult content creator Lily Phillips is getting candid about the plastic surgery procedures she has undergone — and their price tags. “Today I’m going to be doing a surgery tour. I don’t think I’ve ...